Susceptibility of Ureaplasma urealyticum to tetracycline, doxycycline, erythromycin, roxithromycin, clarithromycin, azithromycin, levofloxacin and moxifloxacin

Z. Samra, S. Rosenberg, M. Dan

Research output: Contribution to journalArticlepeer-review

Abstract

The in vitro activity of tetracycline, doxycycline, erythromycin, roxithromycin, clarithromycin, azithromycin, levofloxacin and moxifloxacin was tested against 63 clinical isolates of Ureaplasma urealyticum. The minimal inhibitory concentrations (MICs) and the minimal bactericidal concentrations (MBCs) were determined by the broth microdilution method in A7 medium. The MIC50 and MIC90 of the tested agents after 24 h of incubation were as follows: tetracycline, 0.5 and 2.0 mg/ml; doxycycline, 0.125 and 0.25 mg/ml; erythromycin, 2.0 and 8.0 μg/ml; roxithromycin, 2.0 and 4.0 μg/ml; clarithromycin, 0.25 and 1.0 μg/ml; azithromycin, 2.0 and 4.0 μg/ml; levofloxacin, 1.0 and 2.0 μg/ml; and moxifloxacin, 0.5 and 0.5 μg/ml, respectively. The MIC values after 24 h and 48 h incubation differed by no more than one dilution for all the agents with the exception of doxycycline (two dilution difference for MIC90). Overall, moxifloxacin was the most active agent in vitro against U. urealyticum, with the narrowest difference between MIC and MBC values, followed closely by levofloxacin. Clarithromycin was the most active macrolide.

Original languageEnglish
Pages (from-to)77-79
Number of pages3
JournalJournal of Chemotherapy
Volume23
Issue number2
DOIs
StatePublished - Apr 2011

Keywords

  • Antimicrobial susceptibility
  • Azithromycin
  • Clarithromycin
  • Levofloxacin
  • Moxifloxacin
  • Roxithromycin
  • Ureaplasma

Fingerprint

Dive into the research topics of 'Susceptibility of Ureaplasma urealyticum to tetracycline, doxycycline, erythromycin, roxithromycin, clarithromycin, azithromycin, levofloxacin and moxifloxacin'. Together they form a unique fingerprint.

Cite this